Skip to content
Wenlo
Sign in
← Markets

BridgeBio Pharma Inc.

BridgeBio Pharma Inc. (BBIO) — Form 4: Insider transaction

4BBIOFiled Nov 18, 2026, 2:39 PM ET· Period Nov 16, 2026

About this filing

BridgeBio Pharma Inc. (BBIO) filed Form 4 (insider transaction) with the SEC on Nov 18, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.

More BBIO filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.